KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Non-Current Liabilities: 2017-2024

Historic Other Non-Current Liabilities for Elanco Animal Health (ELAN) over the last 8 years, with Dec 2024 value amounting to $477.0 million.

  • Elanco Animal Health's Other Non-Current Liabilities rose 3.41% to $607.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $607.0 million, marking a year-over-year increase of 3.41%. This contributed to the annual value of $477.0 million for FY2024, which is 16.06% up from last year.
  • As of FY2024, Elanco Animal Health's Other Non-Current Liabilities stood at $477.0 million, which was up 16.06% from $411.0 million recorded in FY2023.
  • In the past 5 years, Elanco Animal Health's Other Non-Current Liabilities registered a high of $477.0 million during FY2024, and its lowest value of $229.0 million during FY2022.
  • For the 3-year period, Elanco Animal Health's Other Non-Current Liabilities averaged around $372.3 million, with its median value being $411.0 million (2023).
  • In the last 5 years, Elanco Animal Health's Other Non-Current Liabilities surged by 202.06% in 2020 and then decreased by 18.63% in 2021.
  • Over the past 5 years, Elanco Animal Health's Other Non-Current Liabilities (MRY) stood at $322.0 million in 2020, then fell by 18.63% to $262.0 million in 2021, then decreased by 12.60% to $229.0 million in 2022, then surged by 79.48% to $411.0 million in 2023, then rose by 16.06% to $477.0 million in 2024.
  • Its last three reported values are $477.0 million in FY2024, $411.0 million for FY2023, and $229.0 million during FY2022.